Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Home - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 389545 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Printer Friendly
PDF Brochure
Send to Friend
Enquire before Buying
Hard CopyAdd to Basket
ElectronicAdd to Basket



Emerging Markets Series: Benchmarking Key Countries Brazil, Russia, India, China and Turkey
Datamonitor, Jan 2008, Pages: 407


  Description  
  Table of Contents  
  Companies Mentioned  
    
    
   
 Enquire before Buying  
 Send to a Friend  

Introduction

With dwindling growth rates observed in the major developed markets many pharmaceutical companies are turning towards emerging market countries in order to sustain their revenue growth. While some countries, with double digit growth rates present tremendous opportunities, there are also many obstacles that need to be overcome.

Scope
- Review of the key macroeconomic trends and business environment in analyzed countries
- In-depth analysis of the healthcare system dynamics in key emerging markets
- Analysis of the pharmaceutical market dynamics in analyzed emerging markets
- Overview of the outsourcing opportunities for key emerging markets

Highlights

Fast economic growth, increasing economic and political stability coupled with tremendous patient potential and increased Westernization of lifestyle present new opportunities for global pharmaceutical companies. Despite problematic intellectual property protection high market potential is attracting most multinational pharmaceutical companies.

Healthcare system characteristics differ greatly between different emerging market countries. Greater state participation in healthcare provision is observed in all markets although growing disposable income and out-of-pocket expenditure are contributing to market growth.

The changing medical needs of the emerging countries are favoring multinational companies: sales of anti-infective agents are slowing down and cancer drugs, immunomodulatory and respiratory drugs among others are growing at fast rates. With increasing purchasing power consumer preference for expensive new treatments is growing.

Reasons to Purchase
- Identify the key trends that are driving and resisting the growth of the pharmaceutical market in key developing countries
- Understand the macroeconomic factors and healthcare system characteristics impacting the pharmaceutical market in the analyzed countries
- Gain insight into current market dynamics and opportunities and challenges for foreign companies wishing to enter these emerging markets




Customers who bought this item also bought

Snapshots Russia Advertising 2007

Snapshots Russia Magazines 2007

Snapshots Russia Newspapers 2007

Snapshots Russia Beer 2007

Snapshots Russia Chocolate Confectionery 2007

Dynamics of Pharmacy Drugs Sales in Russia(March-May 2005) (with Appendix: Russian Pharmaceutical Market Issue: August 2005)

Wound Treatments in Russia

The Pharmaceutical Market: Russia



Top of page


   All rights reserved. � Copyright 2008 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster


Research and Markets RSS Feeds